160 results
424B3
CRVO
CervoMed Inc
6 Jun 24
Prospectus supplement
6:03am
. Internal Revenue Code of 1986, as amended
CREATES Act
the Creating and Restoring Equal Access to Equivalent Samples Act of 2019
CRL
Complete Response … was granted access to $7.3 million under the NIA Grant in February 2024, 90% of the full amount of the second year of funding provided for in the NIA Grant
8-K
EX-10.1
pgm5 z0v9
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
8-K/A
EX-99.3
pce17y w05dh1kx6im
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.2
0b381p 5ptvwv7xmyz
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
EX-3.5
fjxth0cn4476h4lz
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
EX-4.2
eqletsr8g
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
425
EX-99.1
mnxxr678o ojepo6x8
14 Aug 23
Business combination disclosure
4:16pm
8-K
EX-99.1
afg 05kuqzz4
14 Aug 23
EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies
4:15pm
425
yk7ozok esp
3 Aug 23
Business combination disclosure
4:15pm
8-K
qpnc9nn 2mor
3 Aug 23
Other Events
4:15pm
425
EX-99.1
h0p9hh9inq61j5j7r
3 Aug 23
Business combination disclosure
8:33am
8-K
EX-99.1
nckfj1xbypt685bxu
3 Aug 23
EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference
8:32am